MURRYSVILLE, Pa. — During Medtrade last month, Philips Home Healthcare Solutions CEO John L. Miclot announced he had resigned from Philips Respironics to take the top spot at CCS Medical.
Based in Clearwater, Fla., CCS is one of the nation's largest providers of respiratory medications and diabetes testing supplies to Medicare beneficiaries, offering mail-order delivery of HME including blood glucose meters, catheters, insulin pumps, nebulizers and ostomy, urological and wound care supplies.
Formed by the merger of Chronic Care Solutions and MP TotalCare, CCS is majority-owned by private equity investor Warburg Pincus. Ranked No. 56 on Inc.'s 2007 list of Top 100 companies by dollars of growth and No. 64 in revenues, the company had 2006 sales of $432 million and currently operates offices in seven states with 1,600 employees.
After joining Respironics in 1998 as group vice president, sleep disorders, Miclot was tapped to lead the company in late 2003. He was named CEO of Philips Home Healthcare Solutions following Respironics' acquisition by Philips in a $5.1 billion deal earlier this year.
Currently serving as president of sleep and home respiratory for Philips Respironics, Donald J. Spence will succeed Miclot. At a press event during the Atlanta trade show, Spence noted he had big shoes to fill and joked that, with CCS as a potential customer, "I don't look forward to the negotiating sessions."
